| abstract |
The present invention is related to newnpeptides and the nucleic acid molecules encoding saidnpeptides. n The present invention concerns also thenvector comprising said nucleic acid molecules, cellsntransformed by said vector, inhibitors directed againstnsaid peptides or said nucleic acid molecules, anpharmaceutical composition and a diagnostic and/or dosagendevice comprising said products, and non human transgenicnanimals expressing the peptides according to the inventionnor the nucleic acid molecules encoding said peptides. |